Tucker M J, Morton P C, Wright G, Ingargiola P E, Sweitzer C L, Elsner C W, Mitchell-Leef D E, Massey J B
Reproductive Biology Associates, Atlanta, GA 30342, USA.
Hum Reprod. 1996 Nov;11(11):2434-7. doi: 10.1093/oxfordjournals.humrep.a019131.
In two separate prospectively randomized trials, intracytoplasmic sperm injection (ICSI) cycles were studied in a controlled manner to monitor the effects of either bovine oviductal epithelial cell co-culture (n = 119) or assisted hatching by zona drilling (n = 100). In the first study, immediately following ICSI, all eggs were placed directly either onto partial monolayers of bovine oviductal cells or into regular culture medium. Although the embryo developmental rate was apparently compromised in part by the presence of the co-culture cells, ultimately there were no significant differences in either the viable pregnancy rate (31.6% co-culture versus 29.0% control) or the embryonic implantation rate (11.4% co-culture versus 13.6% control). Assisted hatching also had no significant impact on ICSI cycle outcome in terms of either the viable pregnancy rate (30.0% assisted hatching versus 32.0% control) or the embryonic implantation rate (8.5% assisted hatching versus 13.5% control). However, in female patients aged > or = 35 years, assisted hatching appeared to convey a marginally significant benefit in terms of both the viable pregnancy rate (35.5% assisted hatching versus 11.1% control) and the embryonic implantation rate (10.3% assisted hatching versus 3.1% control). It seems that the overall improvement of ICSI cycle outcome cannot be achieved by the general application of either co-culture or assisted hatching. Nevertheless, it is possible that there remain specific patient groups that might benefit from selected use of either of these modalities.
在两项独立的前瞻性随机试验中,以对照方式研究了胞浆内单精子注射(ICSI)周期,以监测牛输卵管上皮细胞共培养(n = 119)或通过 zona 钻孔进行辅助孵化(n = 100)的效果。在第一项研究中,ICSI 后立即将所有卵子直接置于牛输卵管细胞的部分单层上或放入常规培养基中。尽管共培养细胞的存在部分地明显损害了胚胎发育率,但最终在活产妊娠率(共培养组为 31.6%,对照组为 29.0%)或胚胎着床率(共培养组为 11.4%,对照组为 13.6%)方面均无显著差异。辅助孵化在活产妊娠率(辅助孵化组为 30.0%,对照组为 32.0%)或胚胎着床率(辅助孵化组为 8.5%,对照组为 13.5%)方面对 ICSI 周期结局也没有显著影响。然而,在年龄≥35 岁的女性患者中,辅助孵化在活产妊娠率(辅助孵化组为 35.5%,对照组为 11.1%)和胚胎着床率(辅助孵化组为 10.3%,对照组为 3.1%)方面似乎都有略微显著的益处。看来,通过普遍应用共培养或辅助孵化并不能实现 ICSI 周期结局的总体改善。然而,可能仍有特定患者群体可能从这些方式中的任何一种的选择性使用中受益。